Cite

HARVARD Citation

    Noh, H. et al. (2018). Cell surface vimentin-targeted monoclonal antibody 86C increases sensitivity to temozolomide in glioma stem cells. Cancer letters. pp. 176-185. [Online]. 
  
Back to record